Harsha Kantamneni
CEO, Hado Therapeutics Ltd
We discover pioneering medicines for diseases ranging from rare disorders to indications of significant disease burden. Hado discovered first-in-class compounds for treating Glioblastoma, Parkinson's disease, Diabetic Neuropathy and Bleeding disorders.
Events Harsha Kantamneni has spoken at
- BioTrinity 2026 14 April 2026 – 15 April 2026